Global Pet Deworming Drugs Market Growth 2022-2028
The global market for Pet Deworming Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Pet Deworming Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Pet Deworming Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Pet Deworming Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Pet Deworming Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Pet Deworming Drugs players cover Advantage Multi, Bayer, Bimeda Animal Health, Boehringer Ingelheim and Dechra Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Pet Deworming Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Pet Deworming Drugs market, with both quantitative and qualitative data, to help readers understand how the Pet Deworming Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Pet Deworming Drugs market and forecasts the market size by Type (Injecting Drugs, Oral Drugs and Others), by Application (Cats, Dogs and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Injecting Drugs
Oral Drugs
Others
Segmentation by application
Cats
Dogs
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Advantage Multi
Bayer
Bimeda Animal Health
Boehringer Ingelheim
Dechra Pharmaceuticals
Droncit
Drontal Plus
Elanco
Merck
Trifexis
Vetoquinol
Zoetis
Chapter Introduction
Chapter 1: Scope of Pet Deworming Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global Pet Deworming Drugs market size (sales and revenue) and CAGR, Pet Deworming Drugs market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Pet Deworming Drugs sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Pet Deworming Drugs sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Pet Deworming Drugs market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Advantage Multi, Bayer, Bimeda Animal Health, Boehringer Ingelheim, Dechra Pharmaceuticals, Droncit, Drontal Plus, Elanco and Merck, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pet Deworming Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pet Deworming Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pet Deworming Drugs by Country/Region, 2017, 2022 & 2028
2.2 Pet Deworming Drugs Segment by Type
2.2.1 Injecting Drugs
2.2.2 Oral Drugs
2.2.3 Others
2.3 Pet Deworming Drugs Sales by Type
2.3.1 Global Pet Deworming Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Pet Deworming Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pet Deworming Drugs Sale Price by Type (2017-2022)
2.4 Pet Deworming Drugs Segment by Application
2.4.1 Cats
2.4.2 Dogs
2.4.3 Others
2.5 Pet Deworming Drugs Sales by Application
2.5.1 Global Pet Deworming Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Pet Deworming Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pet Deworming Drugs Sale Price by Application (2017-2022)
3 Global Pet Deworming Drugs by Company
3.1 Global Pet Deworming Drugs Breakdown Data by Company
3.1.1 Global Pet Deworming Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Pet Deworming Drugs Sales Market Share by Company (2020-2022)
3.2 Global Pet Deworming Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Pet Deworming Drugs Revenue by Company (2020-2022)
3.2.2 Global Pet Deworming Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Pet Deworming Drugs Sale Price by Company
3.4 Key Manufacturers Pet Deworming Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Deworming Drugs Product Location Distribution
3.4.2 Players Pet Deworming Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pet Deworming Drugs by Geographic Region
4.1 World Historic Pet Deworming Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Pet Deworming Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pet Deworming Drugs Annual Revenue by Geographic Region
4.2 World Historic Pet Deworming Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Pet Deworming Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pet Deworming Drugs Annual Revenue by Country/Region
4.3 Americas Pet Deworming Drugs Sales Growth
4.4 APAC Pet Deworming Drugs Sales Growth
4.5 Europe Pet Deworming Drugs Sales Growth
4.6 Middle East & Africa Pet Deworming Drugs Sales Growth
5 Americas
5.1 Americas Pet Deworming Drugs Sales by Country
5.1.1 Americas Pet Deworming Drugs Sales by Country (2017-2022)
5.1.2 Americas Pet Deworming Drugs Revenue by Country (2017-2022)
5.2 Americas Pet Deworming Drugs Sales by Type
5.3 Americas Pet Deworming Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Deworming Drugs Sales by Region
6.1.1 APAC Pet Deworming Drugs Sales by Region (2017-2022)
6.1.2 APAC Pet Deworming Drugs Revenue by Region (2017-2022)
6.2 APAC Pet Deworming Drugs Sales by Type
6.3 APAC Pet Deworming Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pet Deworming Drugs by Country
7.1.1 Europe Pet Deworming Drugs Sales by Country (2017-2022)
7.1.2 Europe Pet Deworming Drugs Revenue by Country (2017-2022)
7.2 Europe Pet Deworming Drugs Sales by Type
7.3 Europe Pet Deworming Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pet Deworming Drugs by Country
8.1.1 Middle East & Africa Pet Deworming Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pet Deworming Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Pet Deworming Drugs Sales by Type
8.3 Middle East & Africa Pet Deworming Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Deworming Drugs
10.3 Manufacturing Process Analysis of Pet Deworming Drugs
10.4 Industry Chain Structure of Pet Deworming Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Deworming Drugs Distributors
11.3 Pet Deworming Drugs Customer
12 World Forecast Review for Pet Deworming Drugs by Geographic Region
12.1 Global Pet Deworming Drugs Market Size Forecast by Region
12.1.1 Global Pet Deworming Drugs Forecast by Region (2023-2028)
12.1.2 Global Pet Deworming Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pet Deworming Drugs Forecast by Type
12.7 Global Pet Deworming Drugs Forecast by Application
13 Key Players Analysis
13.1 Advantage Multi
13.1.1 Advantage Multi Company Information
13.1.2 Advantage Multi Pet Deworming Drugs Product Offered
13.1.3 Advantage Multi Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Advantage Multi Main Business Overview
13.1.5 Advantage Multi Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Pet Deworming Drugs Product Offered
13.2.3 Bayer Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Bimeda Animal Health
13.3.1 Bimeda Animal Health Company Information
13.3.2 Bimeda Animal Health Pet Deworming Drugs Product Offered
13.3.3 Bimeda Animal Health Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bimeda Animal Health Main Business Overview
13.3.5 Bimeda Animal Health Latest Developments
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Information
13.4.2 Boehringer Ingelheim Pet Deworming Drugs Product Offered
13.4.3 Boehringer Ingelheim Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Boehringer Ingelheim Main Business Overview
13.4.5 Boehringer Ingelheim Latest Developments
13.5 Dechra Pharmaceuticals
13.5.1 Dechra Pharmaceuticals Company Information
13.5.2 Dechra Pharmaceuticals Pet Deworming Drugs Product Offered
13.5.3 Dechra Pharmaceuticals Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Dechra Pharmaceuticals Main Business Overview
13.5.5 Dechra Pharmaceuticals Latest Developments
13.6 Droncit
13.6.1 Droncit Company Information
13.6.2 Droncit Pet Deworming Drugs Product Offered
13.6.3 Droncit Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Droncit Main Business Overview
13.6.5 Droncit Latest Developments
13.7 Drontal Plus
13.7.1 Drontal Plus Company Information
13.7.2 Drontal Plus Pet Deworming Drugs Product Offered
13.7.3 Drontal Plus Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Drontal Plus Main Business Overview
13.7.5 Drontal Plus Latest Developments
13.8 Elanco
13.8.1 Elanco Company Information
13.8.2 Elanco Pet Deworming Drugs Product Offered
13.8.3 Elanco Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Elanco Main Business Overview
13.8.5 Elanco Latest Developments
13.9 Merck
13.9.1 Merck Company Information
13.9.2 Merck Pet Deworming Drugs Product Offered
13.9.3 Merck Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Merck Main Business Overview
13.9.5 Merck Latest Developments
13.10 Trifexis
13.10.1 Trifexis Company Information
13.10.2 Trifexis Pet Deworming Drugs Product Offered
13.10.3 Trifexis Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Trifexis Main Business Overview
13.10.5 Trifexis Latest Developments
13.11 Vetoquinol
13.11.1 Vetoquinol Company Information
13.11.2 Vetoquinol Pet Deworming Drugs Product Offered
13.11.3 Vetoquinol Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Vetoquinol Main Business Overview
13.11.5 Vetoquinol Latest Developments
13.12 Zoetis
13.12.1 Zoetis Company Information
13.12.2 Zoetis Pet Deworming Drugs Product Offered
13.12.3 Zoetis Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Zoetis Main Business Overview
13.12.5 Zoetis Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Pet Deworming Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pet Deworming Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Injecting Drugs
Table 4. Major Players of Oral Drugs
Table 5. Major Players of Others
Table 6. Global Pet Deworming Drugs Sales by Type (2017-2022) & (K Units)
Table 7. Global Pet Deworming Drugs Sales Market Share by Type (2017-2022)
Table 8. Global Pet Deworming Drugs Revenue by Type (2017-2022) & ($ million)
Table 9. Global Pet Deworming Drugs Revenue Market Share by Type (2017-2022)
Table 10. Global Pet Deworming Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Pet Deworming Drugs Sales by Application (2017-2022) & (K Units)
Table 12. Global Pet Deworming Drugs Sales Market Share by Application (2017-2022)
Table 13. Global Pet Deworming Drugs Revenue by Application (2017-2022)
Table 14. Global Pet Deworming Drugs Revenue Market Share by Application (2017-2022)
Table 15. Global Pet Deworming Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Pet Deworming Drugs Sales by Company (2020-2022) & (K Units)
Table 17. Global Pet Deworming Drugs Sales Market Share by Company (2020-2022)
Table 18. Global Pet Deworming Drugs Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Pet Deworming Drugs Revenue Market Share by Company (2020-2022)
Table 20. Global Pet Deworming Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Pet Deworming Drugs Producing Area Distribution and Sales Area
Table 22. Players Pet Deworming Drugs Products Offered
Table 23. Pet Deworming Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Pet Deworming Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Pet Deworming Drugs Sales Market Share Geographic Region (2017-2022)
Table 28. Global Pet Deworming Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Pet Deworming Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Pet Deworming Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Pet Deworming Drugs Sales Market Share by Country/Region (2017-2022)
Table 32. Global Pet Deworming Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Pet Deworming Drugs Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Pet Deworming Drugs Sales by Country (2017-2022) & (K Units)
Table 35. Americas Pet Deworming Drugs Sales Market Share by Country (2017-2022)
Table 36. Americas Pet Deworming Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Pet Deworming Drugs Revenue Market Share by Country (2017-2022)
Table 38. Americas Pet Deworming Drugs Sales by Type (2017-2022) & (K Units)
Table 39. Americas Pet Deworming Drugs Sales Market Share by Type (2017-2022)
Table 40. Americas Pet Deworming Drugs Sales by Application (2017-2022) & (K Units)
Table 41. Americas Pet Deworming Drugs Sales Market Share by Application (2017-2022)
Table 42. APAC Pet Deworming Drugs Sales by Region (2017-2022) & (K Units)
Table 43. APAC Pet Deworming Drugs Sales Market Share by Region (2017-2022)
Table 44. APAC Pet Deworming Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Pet Deworming Drugs Revenue Market Share by Region (2017-2022)
Table 46. APAC Pet Deworming Drugs Sales by Type (2017-2022) & (K Units)
Table 47. APAC Pet Deworming Drugs Sales Market Share by Type (2017-2022)
Table 48. APAC Pet Deworming Drugs Sales by Application (2017-2022) & (K Units)
Table 49. APAC Pet Deworming Drugs Sales Market Share by Application (2017-2022)
Table 50. Europe Pet Deworming Drugs Sales by Country (2017-2022) & (K Units)
Table 51. Europe Pet Deworming Drugs Sales Market Share by Country (2017-2022)
Table 52. Europe Pet Deworming Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Pet Deworming Drugs Revenue Market Share by Country (2017-2022)
Table 54. Europe Pet Deworming Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Europe Pet Deworming Drugs Sales Market Share by Type (2017-2022)
Table 56. Europe Pet Deworming Drugs Sales by Application (2017-2022) & (K Units)
Table 57. Europe Pet Deworming Drugs Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Pet Deworming Drugs Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Pet Deworming Drugs Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Pet Deworming Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Pet Deworming Drugs Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Pet Deworming Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Pet Deworming Drugs Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Pet Deworming Drugs Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Pet Deworming Drugs Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Pet Deworming Drugs
Table 67. Key Market Challenges & Risks of Pet Deworming Drugs
Table 68. Key Industry Trends of Pet Deworming Drugs
Table 69. Pet Deworming Drugs Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Pet Deworming Drugs Distributors List
Table 72. Pet Deworming Drugs Customer List
Table 73. Global Pet Deworming Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Pet Deworming Drugs Sales Market Forecast by Region
Table 75. Global Pet Deworming Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Pet Deworming Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Pet Deworming Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Pet Deworming Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Pet Deworming Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Pet Deworming Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Pet Deworming Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Pet Deworming Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Pet Deworming Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Pet Deworming Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Pet Deworming Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Pet Deworming Drugs Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Pet Deworming Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Pet Deworming Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Pet Deworming Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Pet Deworming Drugs Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Pet Deworming Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Pet Deworming Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 93. Advantage Multi Basic Information, Pet Deworming Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Advantage Multi Pet Deworming Drugs Product Offered
Table 95. Advantage Multi Pet Deworming Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Advantage Multi Main Business
Table 97. Advantage Multi Latest Developments
Table 98. Bayer Basic Information, Pet Deworming Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Bayer Pet Deworming Drugs Product Offered
Table 100. Bayer Pet Deworming Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Bayer Main Business
Table 102. Bayer Latest Developments
Table 103. Bimeda Animal Health Basic Information, Pet Deworming Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Bimeda Animal Health Pet Deworming Drugs Product Offered
Table 105. Bimeda Animal Health Pet Deworming Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Bimeda Animal Health Main Business
Table 107. Bimeda Animal Health Latest Developments
Table 108. Boehringer Ingelheim Basic Information, Pet Deworming Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Boehringer Ingelheim Pet Deworming Drugs Product Offered
Table 110. Boehringer Ingelheim Pet Deworming Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Boehringer Ingelheim Main Business
Table 112. Boehringer Ingelheim Latest Developments
Table 113. Dechra Pharmaceuticals Basic Information, Pet Deworming Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Dechra Pharmaceuticals Pet Deworming Drugs Product Offered
Table 115. Dechra Pharmaceuticals Pet Deworming Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Dechra Pharmaceuticals Main Business
Table 117. Dechra Pharmaceuticals Latest Developments
Table 118. Droncit Basic Information, Pet Deworming Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Droncit Pet Deworming Drugs Product Offered
Table 120. Droncit Pet Deworming Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Droncit Main Business
Table 122. Droncit Latest Developments
Table 123. Drontal Plus Basic Information, Pet Deworming Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Drontal Plus Pet Deworming Drugs Product Offered
Table 125. Drontal Plus Pet Deworming Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Drontal Plus Main Business
Table 127. Drontal Plus Latest Developments
Table 128. Elanco Basic Information, Pet Deworming Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Elanco Pet Deworming Drugs Product Offered
Table 130. Elanco Pet Deworming Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Elanco Main Business
Table 132. Elanco Latest Developments
Table 133. Merck Basic Information, Pet Deworming Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Merck Pet Deworming Drugs Product Offered
Table 135. Merck Pet Deworming Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Merck Main Business
Table 137. Merck Latest Developments
Table 138. Trifexis Basic Information, Pet Deworming Drugs Manufacturing Base, Sales Area and Its Competitors
Table 139. Trifexis Pet Deworming Drugs Product Offered
Table 140. Trifexis Pet Deworming Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Trifexis Main Business
Table 142. Trifexis Latest Developments
Table 143. Vetoquinol Basic Information, Pet Deworming Drugs Manufacturing Base, Sales Area and Its Competitors
Table 144. Vetoquinol Pet Deworming Drugs Product Offered
Table 145. Vetoquinol Pet Deworming Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Vetoquinol Main Business
Table 147. Vetoquinol Latest Developments
Table 148. Zoetis Basic Information, Pet Deworming Drugs Manufacturing Base, Sales Area and Its Competitors
Table 149. Zoetis Pet Deworming Drugs Product Offered
Table 150. Zoetis Pet Deworming Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Zoetis Main Business
Table 152. Zoetis Latest Developments
List of Figures
Figure 1. Picture of Pet Deworming Drugs
Figure 2. Pet Deworming Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Deworming Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Pet Deworming Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pet Deworming Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Injecting Drugs
Figure 10. Product Picture of Oral Drugs
Figure 11. Product Picture of Others
Figure 12. Global Pet Deworming Drugs Sales Market Share by Type in 2021
Figure 13. Global Pet Deworming Drugs Revenue Market Share by Type (2017-2022)
Figure 14. Pet Deworming Drugs Consumed in Cats
Figure 15. Global Pet Deworming Drugs Market: Cats (2017-2022) & (K Units)
Figure 16. Pet Deworming Drugs Consumed in Dogs
Figure 17. Global Pet Deworming Drugs Market: Dogs (2017-2022) & (K Units)
Figure 18. Pet Deworming Drugs Consumed in Others
Figure 19. Global Pet Deworming Drugs Market: Others (2017-2022) & (K Units)
Figure 20. Global Pet Deworming Drugs Sales Market Share by Application (2017-2022)
Figure 21. Global Pet Deworming Drugs Revenue Market Share by Application in 2021
Figure 22. Pet Deworming Drugs Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Pet Deworming Drugs Revenue Market Share by Company in 2021
Figure 24. Global Pet Deworming Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Pet Deworming Drugs Revenue Market Share by Geographic Region in 2021
Figure 26. Global Pet Deworming Drugs Sales Market Share by Region (2017-2022)
Figure 27. Global Pet Deworming Drugs Revenue Market Share by Country/Region in 2021
Figure 28. Americas Pet Deworming Drugs Sales 2017-2022 (K Units)
Figure 29. Americas Pet Deworming Drugs Revenue 2017-2022 ($ Millions)
Figure 30. APAC Pet Deworming Drugs Sales 2017-2022 (K Units)
Figure 31. APAC Pet Deworming Drugs Revenue 2017-2022 ($ Millions)
Figure 32. Europe Pet Deworming Drugs Sales 2017-2022 (K Units)
Figure 33. Europe Pet Deworming Drugs Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Pet Deworming Drugs Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Pet Deworming Drugs Revenue 2017-2022 ($ Millions)
Figure 36. Americas Pet Deworming Drugs Sales Market Share by Country in 2021
Figure 37. Americas Pet Deworming Drugs Revenue Market Share by Country in 2021
Figure 38. United States Pet Deworming Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Pet Deworming Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Pet Deworming Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Pet Deworming Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Pet Deworming Drugs Sales Market Share by Region in 2021
Figure 43. APAC Pet Deworming Drugs Revenue Market Share by Regions in 2021
Figure 44. China Pet Deworming Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Pet Deworming Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Pet Deworming Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Pet Deworming Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Pet Deworming Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Pet Deworming Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Pet Deworming Drugs Sales Market Share by Country in 2021
Figure 51. Europe Pet Deworming Drugs Revenue Market Share by Country in 2021
Figure 52. Germany Pet Deworming Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Pet Deworming Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Pet Deworming Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Pet Deworming Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Pet Deworming Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Pet Deworming Drugs Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Pet Deworming Drugs Revenue Market Share by Country in 2021
Figure 59. Egypt Pet Deworming Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Pet Deworming Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Pet Deworming Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Pet Deworming Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Pet Deworming Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Pet Deworming Drugs in 2021
Figure 65. Manufacturing Process Analysis of Pet Deworming Drugs
Figure 66. Industry Chain Structure of Pet Deworming Drugs
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets